Doctoral training
Tau aggregation inhibitors for the treatment of neurodegenerative diseases.
Understanding the mechanisms of tau aggregation, propagation and cellular machinery involved in aggregated tau degradation would help in identifying therapeutic targets for tauopathies (Alzheimer’s disease, PSP, CTE, FTLD, etc.) and other neurodegenerative diseases. The thesis is focused on studying tau aggregate spreading mechanisms, identifying small molecule inhibitors of tau misfolding and aggregation using in vitro aggregation assays, cell and molecular biology, biochemistry and microscopy techniques. I am also working on the validation of small molecules (selected from in vitro MARK4 kinase activity inhibition assay) on inhibiting microtubule affinity regulating kinase 4 (MARK4) mediated tau phosphorylation using a cell line model.
About me
{{ student.first_name }} {{ student.last_name }} {{ student.degree }}
Spacialization: {{ student.specialization }}
Status: {{ student.status }}. from .
{{ student.first_name }} {{ student.last_name }} {{ student.degree }}
Spacialization: {{ student.specialization }}.
Status: {{ student.status }}. from .
{{ student.first_name }} {{ student.last_name }} {{ student.degree }}
Status: {{ student.status }}. from .
{{ student.first_name }} {{ student.last_name }} {{ student.degree }}
Status: {{ student.status }}. from .
| Project: | {{ topic.label }} |
|---|---|
| Supervisors: | {{ supervisor.fullname }}, |
| Available: | {{ topic.positions }} |
| Intended for: | {{ topic.training.join(', ') }} |
| Summary: |